Sumathi Sivapalasingam M.D.

Sumathi Sivapalasingam, MD has considerable work experience in the field of clinical development, infectious diseases, and public health. Sumathi is currently the Vice President and Head of Clinical Development at Upstream Bio since 2023. Prior to that, they served as the Vice President at Excision BioTherapeutics from 2021 to 2023. Dr. Sivapalasingam also worked as a Senior Director at Regeneron Pharmaceuticals, Inc. from 2012 to 2021, where they led various clinical projects across therapeutic areas and collaborated with external partners. Before that, they worked as an Attending Physician in Infectious Diseases at Bellevue Hospital from 2004 to 2012. Concurrently, they were also the Director of the NYU-Kenya HIV clinic and training program at NYU School of Medicine from 2004 to 2012. In the earlier stages of their career, they served as an Epidemic Intelligence Service Officer at the Centers for Disease Control and Prevention from 1999 to 2001 and as a Lieutenant Commander in the Commissioned Corps of the U.S. Public Health Service from 1999 to 2001. Dr. Sivapalasingam began their medical career as a Resident at New York-Presbyterian Hospital from 1996 to 1999.

Sumathi Sivapalasingam, MD began their education at The Bronx High School of Science from 1982 to 1986, though no degree or specific field of study is mentioned. Sumathi then attended Swarthmore College from 1986 to 1990, earning a Bachelor of Science (BS) degree with honors in Physics. Afterward, they pursued their medical studies at Albert Einstein College of Medicine from 1992 to 1996, earning their Medical Doctor (MD) degree with a focus in Medicine. It is worth noting that they also studied Physics at Swarthmore College, although no specific degree was mentioned for this period.